The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections
NCT05615805 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142
Last updated 2023-04-25
Summary
This is the first randomized controlled trial looking into post-injection rinse volume of standard ophthalmic eyewash and its affect on patient comfort up to 72 hours after injections.
Conditions
- Intravitreal Injection
- Ocular Rinse
- Age-Related Macular Degeneration
- Diabetic Macular Edema
- Cystoid Macular Edema
Interventions
- OTHER
-
OSDI questionnaire
Ocular Surface Disease Index
- OTHER
-
SPEEDII questionnaire
Standardized Patient Evaluation of Eye Dryness II questionnaire
Sponsors & Collaborators
-
University of Oklahoma
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2021-07-30
- Completion
- 2021-10-01
Countries
- United States
Study Locations
More Related Trials
-
Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
NCT02824913 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
NCT05403827 ·Status: COMPLETED ·Phase: PHASE3
-
Comfort Comparison of Intravitreal Injection Eyelid Retraction Techniques
NCT04144985 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Tear Film Quality and Stability in Subjects With Dry Eye Disease Using OC-01 (Varenicline Solution) Nasal Spray 0.03 mg as Compared to Vehicle Control Nasal Spray
NCT05514041 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of VVN461 Ophthalmic Solution
NCT06906198 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation
NCT00349583 ·Status: COMPLETED ·Phase: PHASE4
-
Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK)
NCT05082974 ·Status: COMPLETED ·Phase: PHASE3
-
HU007 Eye Drops in Patients With Dry Eye Syndrome
NCT04384991 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
NCT03162094 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
NCT02798289 ·Status: COMPLETED ·Phase: NA
-
Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
NCT04041856 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Phase 2b Controlled Study of Dosing Techniques - Part B
NCT07161011 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
NCT03920215 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial
NCT05353101 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers
NCT00386958 ·Status: COMPLETED ·Phase: PHASE2
-
Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers
NCT00135824 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
NCT05119920 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients
NCT05661851 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT
NCT06981104 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome
NCT02680158 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
NCT05865379 ·Status: RECRUITING ·Phase: NA
-
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
NCT05759208 ·Status: COMPLETED ·Phase: PHASE2